Type 2 Diabetes: 2 Studies Unlock Clues About Dementia Risk & Brain Health

Translate to Spanish or other 102 languages!

In the United States, nearly 15% of all adultsTrusted Source 18 years or older had diabetes in 2021, and more than 90%Trusted Source of them had type 2 diabetes. Image for illustration purposes
In the United States, nearly 15% of all adultsTrusted Source 18 years or older had diabetes in 2021, and more than 90%Trusted Source of them had type 2 diabetes. Image for illustration purposes
- Advertisement -
  • To help our audience catch up on the latest medical research developments and insights from health experts, we highlight key findings and takeaways from recent research studies that Medical News Today has covered in depth in previous news reporting.
  • Three published studies in August focused on type 2 diabetes and complications related to the condition that hundreds of millions of people are living with worldwide.
  • One study indicates that maintaining stable hemoglobin A1c (HbA1c) over time can help mitigate dementia risk, while another found that a healthy lifestyle can offset brain aging accelerated by diabetes.

In the United States, nearly 15% of all adultsTrusted Source 18 years or older had diabetes in 2021, and more than 90%Trusted Source of them had type 2 diabetes. Worldwide, it is estimated that the prevalence of diabetes will drastically increase over the next 20 years, according to projections by the International Diabetes Federation.

Follow the link below to Medical News Today for the full story:

https://www.medicalnewstoday.com/articles/type-2-diabetes-studies-healthy-lifestyle-dementia-risk-brain-aging?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-09-09&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Physicians Warn of Rising ER Visits Linked to E-Bikes and Scooters

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...

How Anthocyanins Give Blueberries Their Superfood Status

If you like blueberries, or have been thinking about trying them, you may be surprised to know this tiny fruit offers some big health benefits.

Endocrine Society Outlines Strict Rules for Safe Testosterone Therapy

The Society’s Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices. 
- Advertisement -